Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

Cited In for PubMed (Select 9541335)

1.

Sex-specific brain deficits in auditory processing in an animal model of cocaine-related schizophrenic disorders.

Broderick PA, Rosenbaum T.

Brain Sci. 2013 Apr 10;3(2):504-20. doi: 10.3390/brainsci3020504.

2.

Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure.

Salo R, Fassbender C, Iosif AM, Ursu S, Leamon MH, Carter C.

Psychiatry Res. 2013 Dec 15;210(2):529-35. doi: 10.1016/j.psychres.2013.06.030. Epub 2013 Jul 26.

3.

Neurologic manifestations of chronic methamphetamine abuse.

Rusyniak DE.

Psychiatr Clin North Am. 2013 Jun;36(2):261-75. doi: 10.1016/j.psc.2013.02.005. Epub 2013 Apr 11. Review.

4.

Variants in the 15q25 gene cluster are associated with risk for schizophrenia and bipolar disorder.

Jackson KJ, Fanous AH, Chen J, Kendler KS, Chen X.

Psychiatr Genet. 2013 Feb;23(1):20-8. doi: 10.1097/YPG.0b013e32835bd5f1.

5.

Patterns of Tobacco Consumption among Indian Men with Schizophrenia Compared to Their Male Siblings.

Vatss S, Mehar H, Bhatia T, Richard J, Gur RC, Gur RE, Nimgaonkar VL, Deshpande SN.

Psychiatry Investig. 2012 Sep;9(3):245-51. Epub 2012 Sep 6.

6.

A novel SNP in COMT is associated with alcohol dependence but not opiate or nicotine dependence: a case control study.

Voisey J, Swagell CD, Hughes IP, Lawford BR, Young RM, Morris CP.

Behav Brain Funct. 2011 Dec 31;7:51. doi: 10.1186/1744-9081-7-51.

7.

Neurologic manifestations of chronic methamphetamine abuse.

Rusyniak DE.

Neurol Clin. 2011 Aug;29(3):641-55. doi: 10.1016/j.ncl.2011.05.004. Epub 2011 Jun 24. Review.

8.

Demographic and clinical correlates of substance abuse comorbidity in schizophrenia.

Aich TK, Sinha VK, Khess CR, Singh S.

Indian J Psychiatry. 2004 Apr;46(2):135-9.

9.

Auditory steady state response in bipolar disorder: relation to clinical state, cognitive performance, medication status, and substance disorders.

Rass O, Krishnan G, Brenner CA, Hetrick WP, Merrill CC, Shekhar A, O'Donnell BF.

Bipolar Disord. 2010 Dec;12(8):793-803. doi: 10.1111/j.1399-5618.2010.00871.x.

11.

GABAergic modulation of the 40 Hz auditory steady-state response in a rat model of schizophrenia.

Vohs JL, Chambers RA, Krishnan GP, O'Donnell BF, Berg S, Morzorati SL.

Int J Neuropsychopharmacol. 2010 May;13(4):487-97. doi: 10.1017/S1461145709990307. Epub 2009 Jul 23.

12.

Novel research translates to clinical cases of schizophrenic and cocaine psychosis.

Nunes JV, Broderick PA.

Neuropsychiatr Dis Treat. 2007 Aug;3(4):475-85.

13.

Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophrenia.

Smith MJ, Barch DM, Wolf TJ, Mamah D, Csernansky JG.

Schizophr Res. 2008 Dec;106(2-3):294-9. doi: 10.1016/j.schres.2008.07.015. Epub 2008 Sep 5.

15.

Substance abuse and schizophrenia: pharmacotherapeutic intervention.

Green AI, Noordsy DL, Brunette MF, O'Keefe C.

J Subst Abuse Treat. 2008 Jan;34(1):61-71. Epub 2007 Jun 15. Review.

16.
17.

Substance abuse in patients with schizophrenia.

Winklbaur B, Ebner N, Sachs G, Thau K, Fischer G.

Dialogues Clin Neurosci. 2006;8(1):37-43. Review.

18.

Substance abuse in first-episode schizophrenic patients: a retrospective study.

Mauri MC, Volonteri LS, De Gaspari IF, Colasanti A, Brambilla MA, Cerruti L.

Clin Pract Epidemiol Ment Health. 2006 Mar 23;2:4.

20.

Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study).

García-Cabeza I, Gómez JC, Sacristán JA, Edgell E, González de Chavez M.

BMC Psychiatry. 2001;1:7. Epub 2001 Dec 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk